DOI: 10.1007/s00259-017-3670-zPages: 1014-1024

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

1. UCLA, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine

2. Ludwig-Maximilians-University of Munich, Department of Nuclear Medicine

3. Technical University of Munich, Department of Nuclear Medicine, Klinikum Rechts der Isar

4. St. Vincent’s Hospital, Department of Nuclear Medicine & Endocrinology, PET-CT Center

5. UCL/UCLH, Institute of Nuclear Medicine

6. University of Bologna, S. Orsola Hospital Bologna, Nuclear Medicine Unit

7. University of Wisconsin School of Medicine and Public Health, Department of Radiology

8. University Hospital Heidelberg and DKFZ Heidelberg, Department of Nuclear Medicine

9. University of California, Department of Radiology and Biomedical Imaging

10. German Cancer Research Center (DKFZ) Heidelberg, Division of Radiopharmaceutical Chemistry

11. University Medical Center, University of Rostock, Department of Nuclear Medicine

12. University Hospital RWTH Aachen University, Department of Nuclear Medicine

13. Maastricht University Medical Center (MUMC+), Department of Nuclear Medicine

14. Memorial Sloan-Kettering Cancer Center

15. University of Iowa Hospitals and Clinics, Department of Radiology

16. Technische Universität München, Pharmaceutical Radiochemistry

17. Universitätsklinikum Essen, Klinik für Nuklearmedizin

Correspondence to:
Ken Herrmann



The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of 68Ga-PSMA PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of 68Ga-PSMA PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.

To access the full text, please Sign in

If you have institutional access, please click here

  • Online: Mar 10, 2017

Article Tools